Exchange Announcement • 09 Dec 2024 06:24
Exchange Announcement • 09 Dec 2024 06:21
Exchange Announcement • 09 Dec 2024 06:21
Exchange Announcement • 05 Dec 2024 14:25
Exchange Announcement • 05 Dec 2024 14:12
ENTITY
Paradigm Biopharmaceuticals (PAR AU)
Paradigm Biopharmaceuticals (PAR AU)
21
Analysis
Health Care • Australia
Paradigm Biopharmaceuticals Limited operates as a biopharmaceutical company. The Company develops PPS drug to treat respiratory diseases such as allergic asthma, allergic rhinitis, and chronic obstructive pulmonary. Paradigm Biopharmaceuticals offers its services in Australia.
more
x